The Realme UI 7.0 beta update is now available for 11 new Realme phones, allowing more users to early access the latest ...

European Commission approves Sanofi’s Teizeild to treat patients with stage 2 type 1 diabetes: Paris Tuesday, January 13, 2026, 11:00 Hrs [IST] The European Commission has appro ...

Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...

If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the ...

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...

Anthropic is pushing into the healthcare market as it launches artificial intelligence tools and resources purpose-built for ...

Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetesIf approved, Tzield would be the first ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

OmniOutliner 6 offers multiple powerful improvements and new features that will make any outlining task even more streamlined ...

You can also count fresh herbs like basil, cilantro and parsley as vegetables. While you may not typically eat them in large ...

Anthropic launches Claude for Healthcare, expanding AI tools for clinicians, insurers, and patients.

Some trials show modest improvements in fasting glucose, lipids, or inflammatory markers, possibly via antioxidant or microbiome effects, but robust clinical confirmation is lacking.